Bo Zhang

机构：Union Hospital, Gilead Sciences (Spain), Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-5500-703X

发表论文 4 篇 · 总被引 44 次 · h-index 3

代表论文

• LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m 6 A modification in triple‐negative breast cancer (2024 · Clinical and Translational Medicine · 被引 29)
• m6A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer (2023 · Experimental Cell Research · 被引 12)
• Upregulation of FGF9 and NOVA1 in cancer‐associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer (2024 · Drug Development Research · 被引 3)
• Abstract PO1-06-10: Overall survival results from EVER-132-001, a phase 2b single-arm study of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer (2024 · Cancer Research)